Flexion Therapeutics' IPO

Flexion Therapeutics raised a round of funding on February 12, 2014. Investors include Public.

Flexion Therapeutics discovers and develops therapeutics for musculoskeletal disorders. The company is merging pharmacology with local, sustained delivery of drug to the site of disease - an approach …

Articles about Flexion Therapeutics' IPO: